Tekla Capital Management LLC Blueprint Medicines Corp Transaction History

Tekla Capital Management LLC

$2.53 Billion
Q2 2023

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$41.06 - $66.48 $2.78 Million - $4.5 Million	67,710 New	67,710 $2.97 Million
Q2 2022 Jul 29, 2022	BUY	$45.23 - $70.15 $627,113 - $972,629	13,865 Added 14.26%	111,118 $5.61 Million
Q1 2022 May 13, 2022	BUY	$54.1 - $110.08 $5.26 Million - $10.7 Million	97,253 New	97,253 $6.21 Million
Q3 2021 Nov 12, 2021	SELL	$80.98 - $109.47 $9.94 Million - $13.4 Million	-122,699 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$92.08 - $124.48 $4.36 Million - $5.89 Million	-47,319 Reduced 27.83%	122,699 $13.8 Million
Q3 2020 Nov 13, 2020	BUY	$66.45 - $92.7 $3.44 Million - $4.8 Million	51,762 Added 43.77%	170,018 $15.8 Million
Q2 2020 Aug 13, 2020	SELL	$57.09 - $79.27 $1.2 Million - $1.67 Million	-21,080 Reduced 15.13%	118,256 $9.22 Million
Q1 2020 May 14, 2020	BUY	$48.11 - $82.22 $1.08 Million - $1.84 Million	22,411 Added 19.17%	139,336 $8.15 Million
Q4 2019 Feb 13, 2020	BUY	$66.73 - $82.59 $1.07 Million - $1.32 Million	16,009 Added 15.86%	116,925 $9.37 Million
Q3 2019 Nov 13, 2019	BUY	$72.9 - $101.41 $433,026 - $602,375	5,940 Added 6.25%	100,916 $7.41 Million
Q2 2019 Aug 14, 2019	SELL	$73.54 - $97.8 $1.53 Million - $2.03 Million	-20,744 Reduced 17.93%	94,976 $8.96 Million
Q1 2019 May 14, 2019	SELL	$48.7 - $86.6 $462,016 - $821,574	-9,487 Reduced 7.58%	115,720 $9.26 Million
Q4 2018 Feb 13, 2019	SELL	$45.57 - $74.26 $947,582 - $1.54 Million	-20,794 Reduced 14.24%	125,207 $6.75 Million
Q2 2018 Aug 13, 2018	BUY	$60.96 - $101.18 $4.38 Million - $7.26 Million	71,780 Added 96.71%	146,001 $9.27 Million
Q1 2018 May 14, 2018	BUY	$73.28 - $102.95 $5.44 Million - $7.64 Million	74,221 New	74,221 $6.81 Million

Others Institutions Holding BPMC

# of Institutions

351

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

Vanguard Group Inc Valley Forge, PA

6.68M
Shares

$605 Million
0.01% of portfolio
Black Rock Inc. New York, NY

6.65M
Shares

$601 Million
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

5.39M
Shares

$487 Million
0.06% of portfolio
Wellington Management Group LLP Boston, MA

3.96M
Shares

$359 Million
0.07% of portfolio
State Street Corp Boston, MA

2.77M
Shares

$250 Million
0.01% of portfolio

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Account